Relmada’s depression drug fails to meet late-stage study goal Reuters Oct 14, 2022 Relmada will continue to study REL-1017, its lead treatment, as an adjuntive or in combination with other depression drugs
Sun Pharma to introduce its version of Vortioxetine in India EP News Bureau Mar 30, 2022 Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in…
